摘要
近视是最常见的眼病之一,目前其发病率逐年增加,已成为世界性医学问题。药物治疗和手术治疗是目前的研究热点,并已经取得一定成果。药物应用上存在一定的不良反应,而且远期效果也不明确。手术方面,近视眼手术主要分为角膜屈光手术和眼内屈光手术。各种角膜屈光手术,如LASIK、SBK、飞秒激光、Trans-PRK等技术也日趋成熟。但角膜手术存在着一定的风险,受到近视度数及角膜厚度、形态的限制。眼内屈光手术主要为有晶体眼的人体植入术(PIOL)和屈光性晶状体置换术,其矫正的度数范围更大。本文对有晶体眼人工晶体植入术治疗近视的研究进展进行综述。
Myopia is one of the most common eye diseases.The incidence of myopia is increasing year by year,and it has become a worldwide medical problem.Drug therapy and surgical treatment are the focus of current research,and they have achieved some results.There are some adverse reactions in the use of drugs,and the long-term effect is not clear.In surgery,myopic surgery is mainly divided into the corneal refractive surgery and the intraocular refractive surgery.A variety of corneal refractive surgery is also maturing,such as LASIK,SBK,femtosecond laser,Trans-PRK.However,there are some risks in corneal surgery,which are limited by the degree of myopia and corneal thickness and shape.Intraocular refractive surgery mainly consists of phakic intraocular lens implantation(PIOL) and photorefractive lens replacement,the range of correction is greater.In this paper,the research progress of phakic intraocular lens implantation in the treatment of myopia is reviewed.
出处
《中国社区医师》
2017年第34期13-15,19,共4页
Chinese Community Doctors
关键词
近视
有晶体眼人工晶体植入
临床疗效
并发症
Myopia
Phakic intraocular lens implantation
Clinical efficacy
Complication
